Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vattulainen

Showing results (211-220 of 309) with videos related to

Pageof 31
Sort By:
BMJ (Clinical Research Ed.)|March 8, 2019
Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control studyHanna Savolainen-Peltonen, Päivi Rahkola-Soisalo, Fabian Hoti, et al.
Maturitas|April 28, 2015
The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort studyPauliina Tuomikoski, Heli Lyytinen, Pasi Korhonen, et al.
Chemosphere|May 10, 2003
Analyses of known and new types of polyhalogenated aromatic substances in oven ash from recycled aluminium productionSeija Sinkkonen, Mirja Lahtiperä, Antero Vattulainen, et al.
Nature Chemical Biology|April 5, 2011
Cholesterol modulates glycolipid conformation and receptor activityDaniel Lingwood, Beth Binnington, Tomasz Róg, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2015
Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone TherapyTomi S Mikkola, Pauliina Tuomikoski, Heli Lyytinen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 14, 2015
[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative]Pauliina Tuomikoski, Heli Lyytinen, Pasi Korhonen, et al.
Menopause (New York, N.Y.)|March 25, 2015
Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortalityTomi S Mikkola, Pauliina Tuomikoski, Heli Lyytinen, et al.
Journal of the American Chemical Society|May 18, 2010
Membrane proteins diffuse as dynamic complexes with lipidsPerttu S Niemelä, Markus S Miettinen, Luca Monticelli, et al.
The Journal of Physical Chemistry Letters|February 14, 2018
Bobbing of Oxysterols: Molecular Mechanism for Translocation of Tail-Oxidized Sterols through Biological MembranesWaldemar Kulig, Heikki Mikkolainen, Agnieszka Olżyńska, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2016
Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone TherapiesHanna Savolainen-Peltonen, Pauliina Tuomikoski, Pasi Korhonen, et al.
Pageof 31

Showing results (211-220 of 309) with videos related to

Sort By:
Pageof 31
BMJ (Clinical Research Ed.)|March 8, 2019
Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control studyHanna Savolainen-Peltonen, Päivi Rahkola-Soisalo, Fabian Hoti, et al.
Maturitas|April 28, 2015
The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort studyPauliina Tuomikoski, Heli Lyytinen, Pasi Korhonen, et al.
Chemosphere|May 10, 2003
Analyses of known and new types of polyhalogenated aromatic substances in oven ash from recycled aluminium productionSeija Sinkkonen, Mirja Lahtiperä, Antero Vattulainen, et al.
Nature Chemical Biology|April 5, 2011
Cholesterol modulates glycolipid conformation and receptor activityDaniel Lingwood, Beth Binnington, Tomasz Róg, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2015
Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone TherapyTomi S Mikkola, Pauliina Tuomikoski, Heli Lyytinen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 14, 2015
[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative]Pauliina Tuomikoski, Heli Lyytinen, Pasi Korhonen, et al.
Menopause (New York, N.Y.)|March 25, 2015
Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortalityTomi S Mikkola, Pauliina Tuomikoski, Heli Lyytinen, et al.
Journal of the American Chemical Society|May 18, 2010
Membrane proteins diffuse as dynamic complexes with lipidsPerttu S Niemelä, Markus S Miettinen, Luca Monticelli, et al.
The Journal of Physical Chemistry Letters|February 14, 2018
Bobbing of Oxysterols: Molecular Mechanism for Translocation of Tail-Oxidized Sterols through Biological MembranesWaldemar Kulig, Heikki Mikkolainen, Agnieszka Olżyńska, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2016
Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone TherapiesHanna Savolainen-Peltonen, Pauliina Tuomikoski, Pasi Korhonen, et al.
Pageof 31